This article is from the WebMD News Archive
Most U.S. Newborns Get Screening Tests
July 11, 2007 - The March of Dimes reports that nearly 90% of U.S. newborns now get recommended screening for serious disorders -- up from 38% only two years ago.
In 2004, the American College of Medical Genetics recommended that every newborn baby be screened for 29 genetic or functional disorders such as cystic fibrosis, sickle cell anemia, and hearing loss.
By 2005, only 38% of babies were born in states that required 21 or more of these tests. That percentage has swelled to nearly 90% in 2007.
But a half million U.S. babies still are born in states that required screening for only 10 of the 20 core conditions.
That's too bad -- because if diagnosed early, all of these conditions can be managed or treated to prevent devastating consequences.
Currently, the March of Dimes reports that 13 states and the District of Columbia require screening for all 29 conditions.
But some states that have been lagging are catching up quickly. Montana, Kansas, and West Virginia have enacted legislation -- to be implemented next year -- that will require screening for all core conditions.
Here's the March of Dimes' state-by-state list of the number of the 29 conditions for which each state currently requires screening:
- Alabama: 21
- Alaska: 29
- Arizona: 27
- Arkansas: 7
- California: 26
- Colorado: 29
- Connecticut 28
- Delaware: 29
- District of Columbia: 29
- Florida: 28
- Georgia: 28
- Hawaii: 28
- Idaho: 28
- Illinois: 28
- Indiana: 28
- Iowa: 29
- Kansas: 7
- Kentucky: 29
- Louisiana: 28
- Maine: 24
- Maryland: 29
- Massachusetts: 12
- Michigan: 27
- Minnesota: 29
- Mississippi: 29
- Missouri: 28
- Montana: 6
- Nebraska: 10
- Nevada: 27
- New Hampshire: 12
- New Jersey: 23
- New Mexico: 29
- New York: 29
- North Carolina: 26
- North Dakota: 28
- Ohio: 28
- Oklahoma: 10
- Oregon: 23
- Pennsylvania: 9
- Rhode Island: 29
- South Carolina: 28
- South Dakota: 28
- Tennessee: 26
- Texas: 27
- Utah: 28
- Vermont: 28
- Virginia: 29
- Washington: 12
- West Virginia: 7
- Wisconsin: 28
- Wyoming: 29
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information


